No Data
No Data
SoftBank Group aims to acquire shares from OpenAI employees.
[Generating AI] Softbank Group <9984> is reportedly aiming to increase its investment ratio by acquiring up to $1.5 billion (approximately 230 billion yen) worth of shares from employees of the US OpenAI, as multiple sources have revealed. It is reported that Softbank Group's offer for share acquisition is expected to close within the week. <6702> Fujitsu <7046> TDSE <4011> Headwaters.
From semiconductors to software, the risks of tariffs create a divide.
[Generative AI] In the high-tech stock sector, there has been a significant shift in trends over the past month. A shadow has fallen over the once popular semiconductors, while software is reportedly coming into the spotlight. In the usa, it has been reported that money is flowing out of semiconductor stocks due to concerns over overpriced valuations and the risks of a trade war under the upcoming Trump administration. On the other hand, software stocks are riding a wave of momentum boosted by artificial intelligence (ai). <6702> Fujitsu
Digest of emerging markets stocks: Rejiru had a significant continuation, Agile made a substantial rebound.
＜2158＞ FRONTEO 604 +4 rebound. The company announced today that it has decided to implement the auditing AI solution "KIBIT Eye" at Sanwa Securities. "KIBIT Eye" is an auditing AI solution that supports companies in complying with laws, regulations, and various compliance measures by analyzing information exchanged through various communication tools, such as emails, chats, and transcribed call audio data. With this implementation, San
FRONTEO---Rebound, Sanwa Securities decides to introduce audit AI solution 'KIBIT Eye'.
Rebound. The company announced today that it has decided to introduce the audit AI solution "KIBIT Eye" to Sanwa Securities. "KIBIT Eye" is an audit AI solution that supports companies' compliance with laws and regulations by analyzing information exchanged through various communication tools such as emails, chats, and phone call transcripts. This implementation will be integrated with Sanwa Securities' audio text conversion system.
FRONTEO's significant decline, dissatisfaction with the performance of the second quarter of the fiscal year ending in March 2025.
Significantly declined. It was announced after the close of trading on the 14th that the performance of the second quarter of the fiscal year ending March 2025 has been released and is being sold. Revenue is 3.144 billion thousand yen (a decrease of 8.8% compared to the same period last year), operating profit is 0.295 billion yen (a profit compared to an operating loss of 0.492 billion yen in the same period last year), but it seems to be concerned about the decrease in revenue. In addition, it is related to drug repositioning utilizing UBE and the company's AI drug discovery support service specializing in hypothesis generation, called "Drug Discovery AI Factory".
Fronteo 1H Net Y206.00M Vs Loss Y511.00M
No Data
No Data